Product Images Oxcarbazepine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Oxcarbazepine NDC 0615-8153 by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

chemical-structure - oxcarbazepine tabs 150 mg 300 mg sun 1

chemical-structure - oxcarbazepine tabs 150 mg   300 mg sun 1

figure 1 - oxcarbazepine tabs 150 mg 300 mg sun 2

figure 1 - oxcarbazepine tabs 150 mg   300 mg sun 2

The figure shows the Kaplan-Meier estimates of exit rate by treatment group. The log-rank test resulted in a significant p-value of 0.0001. The X-axis represents the time on the trial from day 2 (in days) and the Y-axis represents the exit rate. The treatment group consists of Oxcarbazepine and Placebo.*

figure-2 - oxcarbazepine tabs 150 mg 300 mg sun 3

figure-2 - oxcarbazepine tabs 150 mg   300 mg sun 3

The text is describing a Kaplan-Meier analysis displaying the seizure event rate for two treatment groups (Oxcarbazepine and Placebo) over time. The log-rank test resulted in a p-value of 0.046, indicating a statistically significant difference between the two groups. The x-axis shows the days from the first dose to the first seizure, and the y-axis shows the seizure rate.*

figure-3 - oxcarbazepine tabs 150 mg 300 mg sun 4

figure-3 - oxcarbazepine tabs 150 mg   300 mg sun 4

The figure shows Kaplan-Meier estimates of exit rate by treatment group. The x-axis represents the time to exit in days, while the y-axis represents the exit rate. The exit rate is significantly different between the high and low treatment groups, as indicated by the log-rank test with a p-value of 0.0001. No other information is available in the text.*

figure-4 - oxcarbazepine tabs 150 mg 300 mg sun 5

figure-4 - oxcarbazepine tabs 150 mg   300 mg sun 5

This is a statistical analysis report of the exit rate in a treatment group. The figure shows the Kaplan-Meier estimates of the exit rate and the log-rank test with a p-value of 0.0001. The text below the figure seems to be a random string of characters, possibly resulting from an error in optical character recognition.*

Principal Display Panel Oxcarbazepine 300 mg - oxcarbazepine tabs 150 mg 300 mg sun 6

Principal Display Panel Oxcarbazepine 300 mg - oxcarbazepine tabs 150 mg   300 mg sun 6

This is a label of a medication containing Oxcarbazepine Tabs 150mg, with lot number 8153- and expiration date information. The medicine is manufactured by Sun Pharmaceutical Industries Inc. and distributed by Vangard Labs Inc. It is stored at 20°C to 25°C (68°F to 77°F) and dispensed in a tight container. The label includes details of tablets, human readable text with information like batch numbers, store conditions and expiry dates. It is intended for institutional use only.*

Principal Display Panel Oxcarbazepine 300 mg - oxcarbazepine tabs 150 mg 300 mg sun 7

Principal Display Panel Oxcarbazepine 300 mg - oxcarbazepine tabs 150 mg   300 mg sun 7

This is a package of oxcarbazepine tablets, each containing 300 mg of the active ingredient. The lot number is 8292 with an expiration date not provided. The tablets are intended for institutional use only and are manufactured by Sun. The package includes information on dosage and storage, and lists a trademark for Omnicare.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.